Profil
Micah Zajic worked as a Senior Director of Corporate Strategy at Alexion Pharmaceuticals from 2014 to 2017.
He then worked as the Vice President of Corporate Development at MeiraGTx Ltd.
from 2017 to 2020.
In 2020, he started working at SQZ Biotechnologies Co. as the Chief Financial Officer until 2022.
Mr. Zajic completed his undergraduate degree at Georgetown University.
Anciens postes connus de Micah Zajic
| Sociétés | Poste | Fin |
|---|---|---|
| SQZ BIOTECHNOLOGIES COMPANY | Directeur Financier/CFO | 31/12/2022 |
MeiraGTx Ltd.
 MeiraGTx Ltd. Pharmaceuticals: MajorHealth Technology MeiraGTx Ltd. engages in the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. The company was founded on March 20, 1991 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 01/09/2020 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2017 |
Formation de Micah Zajic
| Georgetown University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SQZ BIOTECHNOLOGIES COMPANY | Health Technology |
| Entreprise privées | 2 |
|---|---|
MeiraGTx Ltd.
MeiraGTx Ltd. Pharmaceuticals: MajorHealth Technology MeiraGTx Ltd. engages in the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. The company was founded on March 20, 1991 and is headquartered in London, the United Kingdom. | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
